Selected Publications and Presentations

Selected Publications and Presentations

Lee DW, Rawson JV, Wade SW. Radiology benefit managers (RBMs): Cost Saving or Cost Shifting? J Am Coll Radiol in press.

Locklear J, Wade S, Palmer L, Jarbrink K, Toghanian S. Real-world treatment patterns and healthcare resource utilization in generalized anxiety disorder (GAD): a retrospective United States database analysis. Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), November 2010, Prague, Czech Republic.

Viswanathan H, Wade SW, Curtis JR, Yu J, White J, Stolshek B, Merinar C, Balasubramanian A, Kallich J, Adams J. Osteoporosis medication adherence and fracture risk among women in a large U.S. health plan. ACR/ARHP Annual Scientific Meeting, November 2010, Atlanta, GA.

Viswanathan H, White J, Wade SW, Yu J, Curtis JR, Stolshek B, Merinar C, Kallich J, Balasubramanian A, Adams J. Assessment of incremental cost of osteoporosis-related fractures among women in a large U.S. managed care population. ACR/ARHP Annual Scientific Meeting, November 2010, Atlanta, GA.

Wade SW, Curtis JR, Yu J, White J, Stolshek B, Merinar C, Balasubramanian A, Kallich J, Adams J, Viswanathan H. Medication adherence and fracture risk among patients using osteoporosis medications in a large U.S. health plan. American Society for Bone and Mineral Research Annual Meeting, October 2010, Toronto, Ontario, Canada (poster).

Viswanathan H, White J, Wade SW, Yu J, Curtis JR, Stolshek B, Merinar C, Kallich J, Balasubramanian A, Adams J. Incremental cost of osteoporosis-related fractures in a large U.S. managed care population. American Society for Bone and Mineral Research Annual Meeting, October 2010, Toronto, Ontario, Canada (poster).

Lee DW, Rawson JR, Wade S. Radiology benefit managers (RBMs): Cost saving or cost shifting? Academy Health Annual Research Meeting, June 2010, Boston, MA (poster).

Tosteson ANA, Do T, Wade S, Anthony M, Downs R. Persistence and switching patterns among women with varied osteoporosis medication histories: 12-month results from POSSIBLE US™. Osteoporosis Int. 2010 Oct;21(10):1769-80.

Woo C, Gao G, Wade S, Hochberg MC. Gastrointestinal side effects in postmenopausal women using osteoporosis therapy: 1-year findings in the POSSIBLE US™ Study. Curr Med Res and Opin. 2010 Apr; 26:1003-1009.

Latini DM, Lerner SP, Wade SW, Lee DW, Quale DZ. Bladder cancer detection, treatment and outcomes: opportunities and challenges. Urology. Feb;75(2):334-9. Epub Dec 4, 2009.

Do T, Wade S, Stewart R, Macarios D, Barrett-Connor E. Impact of Treatment Satisfaction (Perceived Benefits, Convenience, Side Effects) on Persistence with Postmenopausal Osteoporosis (PMO) Therapy. American Society for Bone and Mineral Research Annual Meeting, September 2009, Denver, CO (poster).

Woo C, Gao G, Wade S, Hochberg M. Gastrointestinal Side Effects Associated with Osteoporosis Therapies Among Postmenopausal: 1-Year Findings From the POSSIBLE US™ Study. North American Menopause Society Annual Meeting, September 2009, San Diego, CA (poster).

Lukert B, Wade S, Anthony M, Gao G, Downs R. Practice Patterns Among Internists, Family Practitioners, and Gynecologists in Management of Postmenopausal Osteoporosis (PMO): Results from POSSIBLE US™. North American Menopause Society Annual Meeting, September 2009, San Diego, CA (poster).

Woo C, Gao G, Wade S, Hochberg M. Gastrointestinal Side Effects Associated with Osteoporosis Therapies Among Postmenopausal Women in the United States. American Academy of Nurse Practitioners Annual Meeting, June 2009, Nashville, TN (poster).

Radiation Therapy: A Cornerstone of Quality Cancer Care. White paper researched and written for Medical Imaging and Technology Alliance. http://www.medicalimaging.org/

Barrett-Connor E, Ensrud E, Tosteson ANA, Varon SF, Anthony M, Daizadeh N, Wade S. Design of the POSSIBLE USÔ Study: postmenopausal women’s compliance and persistence with osteoporosis medications. Osteoporosis Int. 2009 Mar;20(3):463-72.

Tosteson ANA, Wade S, Anthony M, Brancato C, Nichols S, Downs RW. Correlates of osteoporosis treatment persistence for patients new to therapy and patients with recent switches: 6-month results from POSSIBLE USÔ. American Society for Bone and Mineral Research Annual Meeting, September 2008, Montreal, Canada (poster).

Woo C, Gao G, Wade S, Hochberg M. Gastrointestinal side effects in postmenopausal U.S. women on osteoporosis therapy: 6-month findings from the POSSIBLE USÔ Study. American Society for Bone and Mineral Research Annual Meeting, September 2008, Montreal, Canada (poster).

Do T, Wade S, Anthony MS, Wagman RB, Downs RW. Medication switching in postmenopausal women on osteoporosis therapy: 6-month findings from the POSSIBLE USÔ Study. American Society for Bone and Mineral Research Annual Meeting, September 2008, Montreal, Canada (poster).

The Value of Imaging: Improving Outcomes and Reducing Costs. White paper researched and written for Medical Imaging and Technology Alliance. http://www.medicalimaging.org/

Barrett-Connor E, Zagari M, Wade S, Ryu S, Fitzpatrick LA. Design of the prospective observational study of osteoporosis medication use in postmenopausal women in the US. American Society for Bone and Mineral Research Annual Meeting, September 2006, Philadelphia, PA (poster).

Ensrud K, Barrett-Connor E, Tosteson A, Wade S, Farivar S, Fitzpatrick LA. Pattern of use of osteoporosis therapies in postmenopausal women: baseline results of POSSIBLE US. American Society for Bone and Mineral Research Annual Meeting, September 2006, Philadelphia, PA (poster).

Wade SW, Magee, G, Metz L, Broder MS. Cost-effectiveness of treatments for dysfunctional uterine bleeding. J Reprod Med. 2006 Jul;51(7):553-62.

Nissenson, A, Wade S, Goodnough LT, Knight, K, Dubois R. Economic burden of anemia in an insured population. J Manag Care Pharm. 2005 Sep;11(7):565-74.

Dubinsky MC, Reyes E, Ofman J, Chiou CF, Wade S, Sandborn WJ. A cost-effectiveness analysis of alternative disease management strategies in patients with Crohn’s disease treated with azathioprine or 6-mercatopurine. Am J Gastroenterol. 2005 Oct;100(10):2239-47.

Borenstein J, Chiou CF, Dean B, Wong J, Wade S. Estimating direct and indirect costs of premenstrual syndrome. J Occup Environ Med. 2005;47:26-33.

Peabody JW, Schau B, Lopez-Vidriero M, Vestbo J, Wade S, Iqbal A. COPD: a prevalence estimation model. Respirology. 2005 Nov;10(5):594-602.

Knight K, Wade S, Balducci L. Prevalence and outcomes of anemia in cancer: a systematic review of the literature. Am J Med. 2004;116:11S-26S.

Wilson A, Longstreth GF, Knight K, Wong J, Wade S, Chiou CF, Barghout V, Frech F, Ofman JJ. Quality of life in managed care patients with irritable bowel syndrome. Manag Care Interface. 2004;17:24-28,34.

Wade SW, Knight K, Wilson A, Dubois R, Goodnough LT, Nissenson AR “The Economic Burden of Anemia in an Insured Population,” International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual International Meeting, May, 2004, Arlington, VA (poster).

Borenstein J, Yu HT, Wade S, Chiou CF, Rapkin A. Effect of an oral contraceptive containing ethinyl estradiol and drospirenone on premenstrual symptomatology and health-related quality of life. J Reprod Med. 2003;48:79-85.

Ofman JJ; Sullivan SD; Neumann PJ; Chiou CF; Henning JM; Wade SW; Hay JW. Examining the value and quality of health economic analyses: implications of utilizing the QHES. J Manag Care Pharm. 2003;9:53-61.

London R, Solis A, Goldberg GA, Wade S, Chan WW. Examination of resource use and clinical interventions associated with chronic kidney disease in a managed care population. J Manag Care Pharm. 2003 May-Jun;9(3):248-55.

Gilberg K, Laouri M, Wade S,Isonaka S,. Analysis of medication use patterns:apparent overuse of antibiotics and underuse of prescription drugs for asthma, depression, and CHF. J Manag Care Pharm. 2003 May-Jun;9(3):232-7.

Tesser J, Gluck O, Lawless G, Wade S, Kadlubek P. “Healthcare Resource Utilization Attributed to Infections in Patients with Rheumatoid Arthritis.” European League Against Rheumatism, European Congress Of Rheumatology, June 2003, Stockholm (Poster).

Dubois RW, Batchlor E, Wade S. Geographic Variation in the Use of Medications: Is Uniformity Good News or Bad? Health Affairs. 2002;21(1):240-250.

Halbert RJ, Zaher C, Wade S, Malin J, Lawless G, Dubois R. Outpatient Cancer Drug Costs. Cancer. February 15, 2002; 94(4): 1142-1150.

Arocho R, Solis A, Wade S, Goldberg G, Tang S. Exploring the methodological challenges of investigating comparison groups with different underlying characteristics: a case study. J Manag Care Pharm. 2002;5:353-359.

Dubois RW, Alexander CM, Wade S, Mosso A, Markson L, Nag S, Berger ML. Growth in use of lipid lowering therapies: are we targeting the right patients? Am J Manag Care. 2002;8:862-867.

London R, Solis A, Goldberg GA, Wade S, Ryu S. Health care resource utilization and the impact of anemia management in patients with chronic kidney disease. Am J Kidney Dis. 2002 Sep;40(3):539-48.

Chiou CF, Wilson A, Longstreth G, Wade S, Wong J, Barghout V, Frech F, Ofman J. “The Relationship Between Irritable Bowel Syndrome, Abdominal Pain/Discomfort, and Indirect Costs.” Digestive Disease Week Annual Meeting, May 2002, San Francisco, CA (poster).

Knight K, Reyes E, Wallace J, Chiou CF, Wade S, Borenstein J. “Cost-Effectiveness Analysis of Long-Term Contraceptive for Women.” International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting, May 2002, Arlington, VA (poster).

Wade SW, Berzon R, Patton MP, Koch P, Batra D. “Patterns of Antidepressant Use and Health Care Costs in Depressed Patients Who Received SSRI Therapy.” International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting, May 2001, Arlington, VA (poster).

Gluck O, Tesser J, Lawless G, Wade SW, Goldberg GA, Batra D, Kadlubek P. “Incidence Of Clinically Relevant Infections Associated With Rheumatoid Arthritis (Ra) Therapies.” European League Against Rheumatism, European Congress Of Rheumatology, June 2001, Prague, Czech Republic (poster).

London R, Goldberg GA, Wade SW. “Comparative Resource Use For Erythropoietin (Epo) Users And Non-Users During Pre-Dialysis.” National Kidney Foundation Clinical Nephrology Meeting, April 2001, Orlando FL (poster).

London R, Goldberg GA, Solis A, Wade SW. “Resource Utilization Pattern Of Patients During Pre-Dialysis.” National Kidney Foundation Clinical Nephrology Meeting, April 2001, Orlando FL (poster).

Cummings J, Duttagupta S, Wade SW, Goldberg GA, Mosso A, Patton M, Haberman M. “Cost Savings Associated With Use Of Donepezil In Managed Care.” American Association of Geriatric Psychiatry Annual Meeting, February 2001, San Francisco, CA (poster).

Dubois RW, Chawla AJ, Neslusan CA, Smith MW, Wade SW. Explaining Drug Spending Trends: Does Perception Match Reality? Health Affairs, 2000;19:231-239.